Effects of Face Masks During Exercise

January 20, 2025 updated by: Simon Driver, Baylor Research Institute

Effects of Face Coverings During Physical Activity

To describe the primary and secondary outcomes of athletes during a Cardiopulmonary Exercise Test (CPET) on a cycle ergometer with and without a face mask.

Study Overview

Study Type

Interventional

Enrollment (Actual)

100

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Texas
      • Frisco, Texas, United States, 75034
        • Baylor Scott & White Sports Therapy & Research at The Star

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 39 years (Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Be able to come to Baylor Scott & White Sports Therapy and Research at The Star in Frisco, Texas twice in three weeks.
  • Be willing to wear a face mask during exercise capacity testing on a stationary bicycle.

Exclusion Criteria:

-

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: No cloth face mask
Cross-over randomization. Participants randomized to this arm will not wear a cloth face mask for Test 1 which they do a progressive step-exercise cycling test to exhaustion
Participants will complete a Cardiopulmonary Exercise test on cycle ergometer in which they will perform progressive step-exercise cycling to exhaustion
Cognitive Performance will be tested using a cognition application on an iPad during the Cardiopulmonary Exercise Test.
Experimental: Cloth face mask
Cross-over randomization. Participants randomized to this arm will wear a cloth face mask for Test 1 which they do a progressive step-exercise cycling test to exhaustion
Participants will complete a Cardiopulmonary Exercise test on cycle ergometer in which they will perform progressive step-exercise cycling to exhaustion
Cognitive Performance will be tested using a cognition application on an iPad during the Cardiopulmonary Exercise Test.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
VO2 max during cardiopulmonary exercise testing on a cycle ergometer
Time Frame: Week 1
Exercise capacity measured by Cosmed K5 metabolic equipment
Week 1
VO2 max during cardiopulmonary exercise testing on a cycle ergometer
Time Frame: Week 2
Exercise capacity measured by Cosmed K5 metabolic equipment
Week 2
Test duration (time) of cardiopulmonary exercise test on a cycle ergometer
Time Frame: Week 1
Total time of test
Week 1
Test duration (time) of cardiopulmonary exercise test on a cycle ergometer
Time Frame: Week 2
Total time of test
Week 2
Reaction time of cognitive performance testing during cardiopulmonary exercise test on a cycle ergometer
Time Frame: Week 1
Cognitive testing will take place at the end of each stage of the CPET. Cognitive testing using the SACL Cognition application on iPad will include a baseline SRT measurement and additional measurements at the end of each stage of the CPET. The baseline will include a 30s session of SRT for familiarization and then a 30s session will be scored. SRT will then be administered for 30s at the end of each stage of the CPET. The SRT task includes a visual stimulus presented on the touchscreen. Subjects will be instructed to press the stimulus on-screen as quickly as possible. Reaction time will be measured on the SRT task. Reaction time is calculated as the average amount of time in seconds between stimulus presentation and user response within a session.
Week 1
Reaction time of cognitive performance testing during cardiopulmonary exercise test on a cycle ergometer
Time Frame: Week 2
Cognitive testing will take place at the end of each stage of the CPET. Cognitive testing using the SACL Cognition application on iPad will include a baseline SRT measurement and additional measurements at the end of each stage of the CPET. The baseline will include a 30s session of SRT for familiarization and then a 30s session will be scored. SRT will then be administered for 30s at the end of each stage of the CPET. The SRT task includes a visual stimulus presented on the touchscreen. Subjects will be instructed to press the stimulus on-screen as quickly as possible. Reaction time will be measured on the SRT task. Reaction time is calculated as the average amount of time in seconds between stimulus presentation and user response within a session.
Week 2
Accuracy of cognitive performance testing during cardiopulmonary exercise test on a cycle ergometer
Time Frame: Week 1
Cognitive testing will take place at the end of each stage of the CPET. Cognitive testing using the SACL Cognition application on iPad will include a baseline SRT measurement and additional measurements at the end of each stage of the CPET. The baseline will include a 30s session of SRT for familiarization and then a 30s session will be scored. SRT will then be administered for 30s at the end of each stage of the CPET. The SRT task includes a visual stimulus presented on the touchscreen. Subjects will be instructed to press the stimulus on-screen as quickly as possible. Accuracy will be measured on the SRT task. Accuracy is calculated as the total number of correct responses to stimuli divided by the total number of stimuli presented during a session (presented as a percentage).
Week 1
Accuracy of cognitive performance testing during cardiopulmonary exercise test on a cycle ergometer
Time Frame: Week 2
Cognitive testing will take place at the end of each stage of the CPET. Cognitive testing using the SACL Cognition application on iPad will include a baseline SRT measurement and additional measurements at the end of each stage of the CPET. The baseline will include a 30s session of SRT for familiarization and then a 30s session will be scored. SRT will then be administered for 30s at the end of each stage of the CPET. The SRT task includes a visual stimulus presented on the touchscreen. Subjects will be instructed to press the stimulus on-screen as quickly as possible. Accuracy will be measured on the SRT task. Accuracy is calculated as the total number of correct responses to stimuli divided by the total number of stimuli presented during a session (presented as a percentage).
Week 2

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Subjective dyspnea rating during cardiopulmonary exercise testing on a cycle ergometer
Time Frame: Week 1
The Modified Borg Dyspnea Scale (0-10) will be used to assess subjective shortness of breath. Measured during each stage of the exercise protocol during cardiopulmonary exercise test on a cycle ergometer.
Week 1
Subjective dyspnea rating during cardiopulmonary exercise testing on a cycle ergometer
Time Frame: Week 2
The Modified Borg Dyspnea Scale (0-10) will be used to assess subjective shortness of breath. Measured during each stage of the exercise protocol during cardiopulmonary exercise test on a cycle ergometer.
Week 2
Ratings of perceived exertion during cardiopulmonary exercise testing on a cycle ergometer
Time Frame: Week 1
The Borg Rating of Perceived Exertion (6-20) scale will be used during the test to assess subjective exertion. Measured during each stage of the exercise protocol during cardiopulmonary exercise test on a cycle ergometer
Week 1
Ratings of perceived exertion during cardiopulmonary exercise testing on a cycle ergometer
Time Frame: Week 2
The Borg Rating of Perceived Exertion (6-20) scale will be used during the test to assess subjective exertion. Measured during each stage of the exercise protocol during cardiopulmonary exercise test on a cycle ergometer
Week 2
Oxygen saturation during cardiopulmonary exercise testing on a cycle ergometer
Time Frame: Week 1
Measured by a pulse oximeter during each stage of the exercise protocol of the cardiopulmonary exercise test on a cycle ergometer
Week 1
Oxygen saturation during cardiopulmonary exercise testing on a cycle ergometer
Time Frame: Week 2
Measured by a pulse oximeter during each stage of the exercise protocol of the cardiopulmonary exercise test on a cycle ergometer
Week 2
Blood lactate during cardiopulmonary exercise testing on a cycle ergometer
Time Frame: Week 1
Blood lactate will be measured pre and post-CPET using a Nova Medical Lactate Plus: Blood Lactate Measuring Meter-Version 2 device.
Week 1
Blood lactate during cardiopulmonary exercise testing on a cycle ergometer
Time Frame: Week 2
Blood lactate will be measured pre and post-CPET using a Nova Medical Lactate Plus: Blood Lactate Measuring Meter-Version 2 device.
Week 2

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 20, 2021

Primary Completion (Actual)

July 1, 2021

Study Completion (Actual)

July 15, 2021

Study Registration Dates

First Submitted

February 9, 2021

First Submitted That Met QC Criteria

April 2, 2021

First Posted (Actual)

April 6, 2021

Study Record Updates

Last Update Posted (Actual)

March 25, 2025

Last Update Submitted That Met QC Criteria

January 20, 2025

Last Verified

October 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • 020-353

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

IPD Plan Description

Considered upon request.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Covid19

Clinical Trials on Cardiopulmonary Exercise Test

Subscribe